Ranibizumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ranibizumab. Educational only — not medical advice.
Labeled uses
CIMERLI is indicated for the treatment of patients with:
Source: FDA labeling via NIH DailyMed (set 4b383d74…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.